文献速递消化系统肿瘤

2024年欧洲癌症死亡率预测:聚焦结直肠癌

European cancer mortality predictions for the year 2024 with focus on colorectal cancer.
PubMed 文献 · Ann Oncol · 2024-01-28

该研究基于世界卫生组织与Eurostat数据库1970年至最近可用年份的癌症死亡证明和人口数据,预测欧盟、五个入口最多国家及英国2024年癌症死亡率,并聚焦结直肠癌。预测欧盟2024年癌症死亡1270800例,男性年龄标准化死亡率123.2/10万(较2018年下降6.5%),女性79.0/10万(下降4.3%)。结直肠癌死亡率在欧盟所有年龄段下降,男性降4.8%、女性降9.5%;英国男性降3.4%但女性升0.3%,50岁以下在意大利、英国、波兰、西班牙男性及德国女性呈不利趋势。

要点

  • 欧盟2024年预测癌症死亡1270800例,男性年龄标准化死亡率123.2/10万(较2018年下降6.5%),女性79.0/10万(下降4.3%)。
  • 欧盟结直肠癌死亡率所有年龄段下降,男性降4.8%、女性降9.5%(较2018年),70岁以上降幅最大。
  • 英国结直肠癌男性年龄标准化死亡率降3.4%,女性升0.3%;50岁以下在意大利、英国、波兰、西班牙男性及德国女性呈不利趋势。

核心结论

  • 欧盟与英国预测癌症死亡率总体仍有利,主要因男性较女性更早戒烟,凸显烟草对欧洲癌症死亡率的持续重要作用。
  • 应关注年轻成人结直肠癌死亡率的预测上升。

研究设计与样本

  • 基于世界卫生组织与Eurostat数据库1970年至最近可用年份的癌症死亡证明和人口数据,预测欧盟、其五个入口最多国家及英国2024年所有癌症及10个最常见癌症部位的死亡数和年龄标准化率。
  • 对joinpoint模型识别出的最近趋势段拟合线性回归,并估算1988年至2024年峰值以来所有癌症和结直肠癌避免的死亡数。

主要发现

  • 预测欧盟2024年癌症死亡1270800例,年龄标准化率为男性123.2/10万(较2018年下降6.5%)、女性79.0/10万(下降4.3%)。
  • 胰腺癌预测率在男女均不利(男性上升1.6%,女性上升4.0%),女性肺癌上升0.3%。
  • 欧盟结直肠癌死亡率所有年龄段下降,男性降4.8%、女性降9.5%(较2018年),70岁以上降幅最大。
  • 英国结直肠癌所有年龄段年龄标准化率男性有利(较2018年下降3.4%),女性不利(上升0.3%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We predicted cancer mortality figures for 2024 for the European Union (EU), its five most populous countries, and the UK. We focused on mortality from colorectal cancer (CRC). MATERIALS AND METHODS: Based on cancer death certification and population data from the World Health Organization and Eurostat databases from 1970 until the most available year, we predicted deaths and age-standardized rates (ASRs) for 2024 for all cancers and the 10 most common cancer sites. We fitted a linear regression to the most recent trend segment identified by the joinpoint model. The number of avoided deaths since the peak in 1988-2024 was estimated for all cancers and CRC. RESULTS: We predicted 1 270 800 cancer deaths for 2024 in the EU, corresponding to ASRs of 123.2/100 000 men (-6.5% versus 2018) and 79.0/100 000 women (-4.3%). Since 1988, about 6.2 million cancer deaths have been avoided in the EU and 1.3 million in the UK. Pancreatic cancer displayed unfavorable predicted rates for both sexes (+1.6% in men and +4.0% in women) and lung cancer for women (+0.3%). The focus on CRC showed falls in mortality at all ages in the EU, by 4.8% for men and 9.5% for women since 2018. The largest declines in CRC mortality are predicted among those 70+ years old. In the UK, projected ASRs for CRC at all ages are favorable for men (-3.4% versus 2018) but not for women (+0.3%). Below age 50 years, CRC mortality showed unfavorable trends in Italy and the UK, in Poland and Spain for men, and in Germany for women. CONCLUSIONS: Predicted cancer mortality rates remain favorable in the EU and the UK, mainly in males due to earlier smoking cessation compared to females, underlining the persisting major role of tobacco on cancer mortality in Europe. Attention should be paid to the predicted increases in CRC mortality in young adults.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Santucci C, Mignozzi S, Malvezzi M, et al. European cancer mortality predictions for the year 2024 with focus on colorectal cancer. Ann Oncol. 2024. PMID: 38286716. doi:10.1016/j.annonc.2023.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。